Science
fromSilicon Canals
1 day agoNuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins - Silicon Canals
An AI-guided end-to-end workflow combining Nuclera's eProtein Discovery and leadXpro's AI/ML will accelerate and de-risk structural and biophysical access to challenging membrane protein targets.